General Information of the Compound
Compound ID
CP0035758
Compound Name
3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindol-2-yl]cyclopent-2-en-1-one
    Show/Hide
Synonyms
277V92K32B
3-((3aR,4R,5S,7aS)-5-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)hexahydro-1H-isoindol-2(3H)-yl)cyclopent-2-enone
3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindol-2-yl]cyclopent-2-en-1-one
860642-69-9
BDBM50277511
CHEMBL447955
D09378
DB12973
FLNYCRJBCNNHRH-OIYLJQICSA-N
GTPL9280
SCHEMBL3183159
Serlopitant
Serlopitant (USAN)
Serlopitant [USAN:INN]
UNII-277V92K32B
VPD 737
VPD-737
compound 17 (Jiang et al. 2009)
mk-0594
    Show/Hide
Structure
Formula
C29H28F7NO2
Molecular Weight
555.534
Canonical SMILES
C[C@@H](O[C@H]1CC[C@@H]2CN(C[C@H]2[C@@H]1c1ccc(F)cc1)C1=CC(=O)CC1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C29H28F7NO2/c1-16(19-10-20(28(31,32)33)12-21(11-19)29(34,35)36)39-26-9-4-18-14-37(23-7-8-24(38)13-23)15-25(18)27(26)17-2-5-22(30)6-3-17/h2-3,5-6,10-13,16,18,25-27H,4,7-9,14-15H2,1H3/t16-,18-,25-,26+,27+/m1/s1
    Show/Hide
InChIKey
FLNYCRJBCNNHRH-OIYLJQICSA-N
CAS
860642-69-9
Physicochemical Property
logP
7.6819
Rotatable Bonds
5
Heavy Atom Count
39
Polar Areas
29.54
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
39

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 23653789
SID: 46526015
ChEMBL ID
CHEMBL447955
DrugBank ID
DB12973
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01410, Substance-P receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  2
1
IC50 = 0.06 nM
   TI
   LI
   LO
   TS
2
IC50 = 9.5 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Serlopitant )
Drug Name Serlopitant
Company Menlo Therapeutics Redwood City, CA
Indication
Prurigo nodularis
Phase 3
Psoriasis vulgaris
Phase 2
Target(s)
Substance-P receptor (TACR1)
Antagonist